Your browser doesn't support javascript.
loading
Correction to: Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer.
Ren, Megan; Orozco, Anali; Shao, Kang; Albanez, Anaseidy; Ortiz, Jeremy; Cao, Boyang; Wang, Lusheng; Barreda, Lilian; Alvarez, Christian S; Garland, Lisa; Wu, Dongjing; Chung, Charles C; Wang, Jiahui; Frone, Megan; Ralon, Sergio; Argueta, Victor; Orozco, Roberto; Gharzouzi, Eduardo; Dean, Michael.
Afiliação
  • Ren M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD, USA.
  • Orozco A; Instituto Cancerologia, Guatemala City, Guatemala.
  • Shao K; BGI-Shenzhen, Beishan Industrial Zone, Shenzhen, 518083, People's Republic of China.
  • Albanez A; Department of Computer Science, City University of Hong Kong, Kowloon, SAR, Hong Kong, People's Republic of China.
  • Ortiz J; Instituto Cancerologia, Guatemala City, Guatemala.
  • Cao B; Instituto Cancerologia, Guatemala City, Guatemala.
  • Wang L; BGI-Shenzhen, Beishan Industrial Zone, Shenzhen, 518083, People's Republic of China.
  • Barreda L; City University of Hong Kong Shenzhen Research Institute, Shenzhen, People's Republic of China.
  • Alvarez CS; Department of Computer Science, City University of Hong Kong, Kowloon, SAR, Hong Kong, People's Republic of China.
  • Garland L; Hospital General San Juan de Dios, Guatemala City, Guatemala.
  • Wu D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD, USA.
  • Chung CC; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Frederick National Laboratory for Cancer Research, Gaithersburg, MD, USA.
  • Wang J; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Frederick National Laboratory for Cancer Research, Gaithersburg, MD, USA.
  • Frone M; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Frederick National Laboratory for Cancer Research, Gaithersburg, MD, USA.
  • Ralon S; Office of Biostatistics and Epidemiology (OBE), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD , 20993-0002, USA.
  • Argueta V; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Frederick National Laboratory for Cancer Research, Gaithersburg, MD, USA.
  • Orozco R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD, USA.
  • Gharzouzi E; Hospital General San Juan de Dios, Guatemala City, Guatemala.
  • Dean M; Hospital General San Juan de Dios, Guatemala City, Guatemala.
Breast Cancer Res Treat ; 191(1): 227, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34751853
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies País como assunto: America central / Guatemala Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies País como assunto: America central / Guatemala Idioma: En Ano de publicação: 2022 Tipo de documento: Article